Stock Analysis on Net

Baxter International Inc. (NYSE:BAX)

$22.49

This company has been moved to the archive! The financial data has not been updated since August 4, 2016.

Analysis of Solvency Ratios
Quarterly Data

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Solvency Ratios (Summary)

Baxter International Inc., solvency ratios (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Debt Ratios
Debt to equity
Debt to capital
Debt to assets
Financial leverage

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).


Debt to Equity
The debt to equity ratio demonstrated a general upward trend from March 2011 through June 2015, rising from 0.65 to a peak of 1.78 in June 2015. This indicates an increasing reliance on debt financing relative to equity during this period. However, following this peak, the ratio sharply declined to 0.37 by June 2016, suggesting a significant reduction in leverage or an increase in equity financing.
Debt to Capital
This ratio mirrored the behavior of debt to equity, gradually increasing from 0.39 in March 2011 to a high of 0.64 in June 2015. It then experienced a considerable decrease to 0.27 by June 2016. The pattern implies a growing composition of debt in the company's capital structure until mid-2015, followed by a marked shift toward less debt reliance.
Debt to Assets
The debt to assets ratio showed a steady rise from 0.25 in March 2011 to a maximum of 0.47 by June 2015, indicating an increasing proportion of assets funded by debt. Subsequently, this ratio dropped sharply to 0.20 in mid-2016, reflecting a reduction in debt levels or asset base changes impacting leverage.
Financial Leverage
Financial leverage increased from 2.59 in the first quarter of 2011 to a peak of 3.76 in June 2015, signifying an increasing use of debt relative to equity in the capital structure. Post-June 2015, there was a notable decrease to 1.88 by June 2016, indicating a decrease in total asset exposure per unit of equity, likely due to deleveraging or equity growth.
Overall Trends and Insights
From 2011 through mid-2015, all the financial leverage indicators showed a trend of increasing leverage, with the company progressively relying more on debt financing relative to equity and assets. The peak values in mid-2015 suggest that this period represented the highest risk leverage point in the analyzed timeframe.
After this peak, a pronounced deleveraging trend is evident across all ratios, reflecting a strategic reduction of debt or an enhancement of equity base, significantly altering the capital structure and likely reducing financial risk. This shift may have implications for credit risk, cost of capital, and company risk profile going forward.
The consistency in directional movement across all four ratios reinforces the credibility of these conclusions, highlighting a clear cyclical pattern in leverage management within the company over the five-year period.

Debt Ratios


Debt to Equity

Baxter International Inc., debt to equity calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Short-term debt
Current maturities of long-term debt and lease obligations
Long-term debt and lease obligations, excluding current maturities
Total debt
 
Total Baxter shareholders’ equity
Solvency Ratio
Debt to equity1
Benchmarks
Debt to Equity, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
Debt to equity = Total debt ÷ Total Baxter shareholders’ equity
= ÷ =

2 Click competitor name to see calculations.


Total Debt
The total debt generally increased from March 2011 to June 2016, starting at $4,374 million and reaching a peak of $14,218 million in June 2015. There was a notable spike in debt during the period from March 2013 to June 2015, with the debt nearly doubling. After this peak, a significant reduction occurred, and by June 2016, total debt had decreased sharply to $3,168 million, which is below the levels observed in the early periods.
Total Baxter Shareholders’ Equity
Shareholders’ equity showed moderate fluctuations but remained relatively stable over the period. It started at $6,734 million in March 2011, experienced minor increases and decreases, and peaked at $9,019 million in March 2016. By June 2016, equity slightly decreased to $8,509 million. The general trend suggests consistent equity levels with some growth, particularly in the latter years.
Debt to Equity Ratio
The debt to equity ratio fluctuated significantly over the period. Initially, it was relatively low and stable, around 0.65 between 2011 and early 2012. It then climbed steadily, peaking at 1.78 in June 2015, reflecting the substantial increase in debt relative to equity during that period. Following the peak, the ratio dropped sharply to 0.37 by June 2016, indicating a reduction in financial leverage and a potential shift toward a more conservative capital structure.
Overall Insights
The data reveals a period of aggressive borrowing or increased leverage between 2013 and mid-2015, followed by a strategic deleveraging phase through to mid-2016. Despite this volatility in debt levels and leverage, shareholders’ equity remained relatively stable with slight growth over the period. This pattern may indicate responsive financial management balancing growth initiatives financed through debt with later consolidation and balance sheet strengthening.

Debt to Capital

Baxter International Inc., debt to capital calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Short-term debt
Current maturities of long-term debt and lease obligations
Long-term debt and lease obligations, excluding current maturities
Total debt
Total Baxter shareholders’ equity
Total capital
Solvency Ratio
Debt to capital1
Benchmarks
Debt to Capital, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =

2 Click competitor name to see calculations.


The analysis of the quarterly financial data reflects significant movements in debt levels, total capital, and leverage ratios over the observed periods.

Total Debt
Total debt exhibited a general upward trend from March 2011 through June 2015, increasing from approximately $4.4 billion to a peak of about $14.2 billion by June 2015. This substantial rise is most notable between March 2015 and June 2015, where debt surged sharply. Subsequently, there was a pronounced decrease in debt levels through the end of the dataset, declining to around $3.2 billion by June 2016.
Total Capital
Total capital also experienced growth during the majority of the period, moving from roughly $11.1 billion in March 2011 to a maximum of approximately $22.2 billion in June 2015. Similar to total debt, total capital increased steadily but faced a reduction following mid-2015, falling to approximately $11.7 billion by June 2016. This suggests that capital structure adjustments accompanied the changes in debt levels.
Debt to Capital Ratio
The leverage ratio, measured as debt to capital, started near 0.39 in March 2011 and steadily rose, peaking at 0.64 in June 2015. This peak corresponds with the highest levels of debt and capital, indicating an increased reliance on debt financing during this period. Post-June 2015, the ratio sharply contracted to 0.27 by June 2016, denoting a substantial deleveraging effort and a reduction in financial risk exposure.

In summary, the quarter-to-quarter financial data indicates that there was a phase of expansion in financial leverage up until mid-2015, marked by rising debt and capital. Following this peak, the organization underwent significant deleveraging, reducing both total debt and capital, and consequently lowering its debt to capital ratio. This pattern reflects a strategic shift towards a more conservative capital structure in the latter stages of the analyzed period.


Debt to Assets

Baxter International Inc., debt to assets calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Short-term debt
Current maturities of long-term debt and lease obligations
Long-term debt and lease obligations, excluding current maturities
Total debt
 
Total assets
Solvency Ratio
Debt to assets1
Benchmarks
Debt to Assets, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
Debt to assets = Total debt ÷ Total assets
= ÷ =

2 Click competitor name to see calculations.


The financial data reveals notable fluctuations in the company's leverage and asset base over the observed periods.

Total Debt
The total debt outstanding displayed a general upward trend from early 2011 through mid-2015, increasing from approximately 4.37 billion US dollars in March 2011 to a peak of about 14.2 billion US dollars by June 2015. This marked escalation was followed by a significant reduction in debt levels, dropping sharply to around 3.17 billion US dollars by June 2016. This pattern suggests a period of substantial borrowing followed by deleveraging or repayment.
Total Assets
Total assets initially showed steady growth, rising from about 17.4 billion US dollars in March 2011 to a peak near 30 billion US dollars in June 2015. Thereafter, assets contracted noticeably over the next year, declining to roughly 16 billion US dollars by June 2016. This decline in asset base corresponds with the reduction in total debt, indicating possible asset sales or write-downs coinciding with deleveraging measures.
Debt to Assets Ratio
The debt-to-assets ratio remained relatively stable around 0.25 to 0.3 during 2011 and 2012, reflecting a balanced leverage structure. Beginning in 2013, the ratio increased markedly, reaching a high of approximately 0.47 in June 2015, signaling a period of heightened financial leverage. Subsequently, the ratio decreased sharply to about 0.20 by mid-2016, aligning with the reduction in total debt and assets, and indicating a move toward a more conservative capital structure.

Overall, the data illustrates a cycle of expansion in the company’s balance sheet accompanied by increased leverage, followed by a phase of contraction and deleveraging. The fluctuation in both asset base and total debt suggests strategic financial management actions taken to adjust leverage and possibly improve financial stability in the later periods.


Financial Leverage

Baxter International Inc., financial leverage calculation (quarterly data)

Microsoft Excel
Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014 Dec 31, 2013 Sep 30, 2013 Jun 30, 2013 Mar 31, 2013 Dec 31, 2012 Sep 30, 2012 Jun 30, 2012 Mar 31, 2012 Dec 31, 2011 Sep 30, 2011 Jun 30, 2011 Mar 31, 2011
Selected Financial Data (US$ in millions)
Total assets
Total Baxter shareholders’ equity
Solvency Ratio
Financial leverage1
Benchmarks
Financial Leverage, Competitors2
Abbott Laboratories
CVS Health Corp.
Elevance Health Inc.
Intuitive Surgical Inc.
Medtronic PLC
UnitedHealth Group Inc.

Based on: 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31), 10-K (reporting date: 2013-12-31), 10-Q (reporting date: 2013-09-30), 10-Q (reporting date: 2013-06-30), 10-Q (reporting date: 2013-03-31), 10-K (reporting date: 2012-12-31), 10-Q (reporting date: 2012-09-30), 10-Q (reporting date: 2012-06-30), 10-Q (reporting date: 2012-03-31), 10-K (reporting date: 2011-12-31), 10-Q (reporting date: 2011-09-30), 10-Q (reporting date: 2011-06-30), 10-Q (reporting date: 2011-03-31).

1 Q2 2016 Calculation
Financial leverage = Total assets ÷ Total Baxter shareholders’ equity
= ÷ =

2 Click competitor name to see calculations.


The analysis of the quarterly financial data reveals several key trends in the company's asset base, equity, and financial leverage over the examined periods.

Total Assets

Total assets exhibited a general upward trajectory from early 2011 through mid-2016, albeit with some fluctuations. Beginning at approximately $17.4 billion in March 2011, assets increased steadily to peak near $30 billion by June 2015. However, significant decreases followed, with assets dropping sharply to around $15.9 billion by June 2016. This pattern suggests that the company experienced growth up to mid-2015, followed by a notable contraction or asset divestiture thereafter.

Total Baxter Shareholders’ Equity

Shareholders’ equity showed moderate growth from $6.7 billion in March 2011 to a high of $9.0 billion in March 2016. The equity values generally increased in a gradual fashion despite some intermittent decreases, such as the dip observed around December 2014 and early 2015. Although equity reached its peak in early 2016, it slightly declined to approximately $8.5 billion by mid-2016. The steady rise in equity suggests ongoing capitalization and retained earnings accumulation, partially offsetting asset volatility seen in later periods.

Financial Leverage

Financial leverage, defined as the ratio of total assets to shareholders’ equity, fluctuated notably throughout the observed timeframe. Initial leverage values hovered around 2.5 to 2.9 from 2011 to 2012, then increased consistently to reach a high of approximately 3.76 in June 2015, reflecting higher reliance on debt or liabilities relative to equity. By 2016, this ratio fell sharply to below 2, signaling deleveraging or a significant reduction in total assets relative to equity. This decrease in leverage coincides with the observed sharp decline in total assets during the same period.

In summary, the company's asset growth through mid-2015 was accompanied by moderate increases in equity and rising leverage, indicating expanded business scale potentially supported by increased borrowing. Post mid-2015, the sudden asset decline and corresponding reduction in leverage may suggest strategic downsizing, asset sales, or restructuring efforts. Equity remained relatively resilient, indicating stability in the company’s capital base despite the changing asset and leverage profile.